Page last updated: 2024-08-26

tuberostemonine and Alveolitis, Fibrosing

tuberostemonine has been researched along with Alveolitis, Fibrosing in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Fu, S; Hu, Y; Lv, X; Song, X; Tang, X; Zhang, M; Zhu, Q1
Cao, F; Liu, M; Liu, Y; Tang, A; Xu, C; Yang, C1

Other Studies

2 other study(ies) available for tuberostemonine and Alveolitis, Fibrosing

ArticleYear
Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways.
    Chinese journal of natural medicines, 2023, Volume: 21, Issue:7

    Topics: Alkaloids; Animals; Fibroblasts; Macrophages; MAP Kinase Signaling System; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Transforming Growth Factor beta

2023
Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis.
    Journal of ethnopharmacology, 2024, Jan-10, Volume: 318, Issue:Pt B

    Topics: Amino Acid Transport System y+; Animals; Bleomycin; Collagen; Ferroptosis; Glutamic Acid; Humans; Hydroxyproline; Ions; Mice; Pulmonary Fibrosis; Transforming Growth Factor beta1

2024